Resistant hypertension and target organ damage

Hypertension Research

Volumn 36, Issue 6, 2013, Pages 485-491

  Muiesan, Maria Lorenza ^a   Salvetti, Massimo ^a   Rizzoni, Damiano ^a   Paini, Anna ^a   Agabiti Rosei, Claudia ^a   Aggiusti, Carlo ^a   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

aortic stiffness; carotid plaque; kidney dysfuction; left ventricular hypertrophy; resistant hypertension

Indexed keywords

SPIRONOLACTONE;

ADULT; ARTERIAL STIFFNESS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERALDOSTERONISM; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROANGIOPATHY; OBESITY; ORGAN INJURY; PREVALENCE; PROGNOSIS; RESISTANT HYPERTENSION; REVIEW; SLEEP DISORDERED BREATHING; TARGET ORGAN; TARGET ORGAN DAMAGE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD VESSELS; DRUG RESISTANCE; HUMANS; HYPERTENSION; KIDNEY; MYOCARDIUM;

EID: 84878905384     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.30     Document Type: Review

References (52)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-e526.
2. Hall WD. Resistant hypertension, secondary hypertension, and hypertensive crises. Cardiol Clin. 2002; 20: 281-219.
3. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, Caldarella MP, Neri M, Cuccurullo F, Mezzetti A. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005; 18: 1422-1428. (Pubitemid 41566669)
4. Papadopoulos DP, Papademetriou V. Resistant hypertension: diagnosis and management. J Cardiovasc Pharmacol Ther 2006; 11: 113-118. (Pubitemid 44449100)
5. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension. A prospective study. Hypertension 1998; 31: 712-718.
6. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 1635-1642.
7. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007 Guidelines for the management of arterial hypertension. The Task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
8. McAlister FA, Lewanczuk RZ, Teo KK. Resistant hypertension: an overview. Can J Cardiol 1996; 12: 822-828. (Pubitemid 26381484)
9. Ram CVS. Management of refractory hypertension. Am J Therapeut 2003; 10: 122-126.
10. Cuspidi C, Vaccarella A, Negri F, Sala C. Resistant hypertension and left ventricular hypertrophy: an overview. J Am Soc Hypertens 2010; 4: 319-324.
11. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001; 19: 2063-2070. (Pubitemid 33035812)
12. Salles G, Leocadio S, Bloch K, Nogueira AR, Muxfeldt E. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension 2005; 46: 1207-1212. (Pubitemid 41533027)
13. Salles G, Cardoso C, Nogueira AR, Bloch K, Muxfeldt E. Importance of the electrocardiographic strain pattern in patients with resistant hypertension. Hypertension 2006; 48: 437-442. (Pubitemid 44253738)
14. Castelpoggi CH, Pereira VS, Fiszman R, Cardoso CRL, Muxfeldt ES, Salles G. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension. Hypertens Res 2009; 32: 591-596.
15. Salles G, Cardoso CRL, Muxfeldt E. Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study. J Hypertens 2009; 27: 1094-1101.
16. Salles G, Cardoso CRL, Fiszman R, Muxfeldt ES. Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension. J Hypertens 2010; 28: 1715-1733.
17. Salles G, Cardoso CRL, Fiszman R, Muxfeldt ES. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. Am Heart J 2010; 159: 833-840.
18. Hernandez-del Rey R, Armario P, Martin-Baranera M, Sanchez P, Cardenas G, Pardell H. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect. Blood Press Monit 1998; 3: 331-337. (Pubitemid 29141972)
19. Oliveras A, Armario P, Hernandez-Del Rey R, Arroyo JA, Poch E, Larrousse M, Roca-Cusachs A, de la Sierra A. Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens 2010; 24: 27-33.
20. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57: 898-902.
21. Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 2012; 5: 837-848.
22. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13: 1091-1095.
23. de Faire U, Lindwall K, Andersson G, Eriksson S. Regression of left ventricular hypertrophy on long-term treatment with captopril of severe hypertensives refractory to standard triple treatment. Eur J Clin Pharmacol 1989; 37: 291-294. (Pubitemid 19242737)
24. Julien J, Dufloux MA, Prasquier R, Chatellier G, Menard D, Plouin PF, Menard J, Corvol P. Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol 1990; 16: 137-142. (Pubitemid 20217055)
25. Gaddam K, Corros C, Pimenta E, Ahmed M, Denney T, Aban I, Inusah S, Gupta H, Lloyd SG, Oparil S, Husain A, Dell'Italia LJ, Calhoun DA. Rapid reversal of left ventricular hypertrophy and intracardiac volume in patients with resistant hypertension and hyperaldosteronism. A prospective clinical study. Hypertension 2010; 55: 1137-1142.
26. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Bohm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012; 59: 901-909.
27. Brandt MC, Reda S, Mahfoud F, Lenski M, Bohm M, Hoppe UC. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol 2012; 60: 1956-1965.
28. Townsend RR. Vascular compliance and arterial calcification: impact on blood pressure reduction. Curr Opin Nephrol Hypertens 2008; 17: 93-98. (Pubitemid 350295204)
29. Pickering TG. Arterial stiffness as a cause of resistant hypertension? J Clin Hypertens 2007; 9: 390-395.
30. Spence JD. Management of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension. Cerebrovasc Dis 2000; 10: 249-254. (Pubitemid 30430068)
31. Schmieder RE, Schmidt BM, Raff U, Bramlage P, Do rfler A, Achenbach S, Schwab J, Kolominsky-Rabas P. Cerebral microangiopathy in treatment-resistant hypertension. Clin Hypertens 2011; 13: 582-587.
32. Figueiredo VN, Yugar-Toledo JC, Martins LC, Martins LB, de Faria AP, de Haro Moraes C, Sierra C, Coca A, Moreno H. Vascular stiffness and endothelial dysfunction: correlations at different levels of blood pressure. Blood Press 2012; 21: 31-38.
33. Martins LC, Figueiredo VN, Quinaglia T, Boer-Martins L, Yugar-Toledo JC, Martin JF, Demacq C, Pimenta E, Calhoun DA, Moreno H Jr. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness. J Hum Hypertens 2011; 25: 532-538.
34. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108: 2230-2235. (Pubitemid 37363040)
35. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28: 785-790. (Pubitemid 26365519)
36. Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, Rezzani R, Boari GE, Zani F, Miclini M, Tiberio GA, Giulini SM, Rosei CA, Bianchi R, Agabiti Rosei E. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab 2006; 91: 2638-2642. (Pubitemid 44024630)
37. Schiffrin EL, Deng LY, Sventek P, Day R. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens 1997; 15: 57-63. (Pubitemid 27075987)
38. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 2005; 18: 1534-1540. (Pubitemid 41814672)
39. Raff U, Harazny JM, Titze SI, Schmidt BM, Michelson G, Schmieder RE. Salt intake determines retinal arteriolar structure in treatment resistant hypertension independent of blood pressure. Atherosclerosis 2012; 222: 235-240.
40. Nogueira Ada R, Fernandes AS, Coutinho ES, Salles GF, Muxfeld ES, Bloch KV. Factors associated with microalbuminuria in resistant hypertension. Int J Cardiol 2007; 121: 86-87. (Pubitemid 47285359)
41. Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Ba r I, Schmieder RE. Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension. J Hypertens 2010; 28: 608-614.
42. Oliveras A, Armario P, Martell-Claros N, Ruilope LM, de la Sierra A. Spanish Society of Hypertension-Resistant Hypertension Registry. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives. Hypertension 2011; 57: 556-560.
43. Barbato A, Galletti F, Iacone R, Cappuccio FP, Rossi G, Ippolito R, Venezia A, Farinaro E, Strazzullo P. Predictors of resistant hypertension in an unselected sample of an adult male population in Italy. Intern Emerg Med 2012; 7: 343-351.
44. Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis 2011; 216: 199-204.
45. Salles GF, Cardoso CR, Pereira VS, Fiszman R, Muxfeldt ES. Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study. J Hypertens 2011; 29: 2014-2023.
46. Muiesan ML, Pasini G, Salvetti M, Calebich S, Zulli R, Castellano M, Rizzoni D, Bettoni G, Cinelli A, Porteri E, Corsetti V, Agabiti-Rosei E. Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study. Hypertension 1996; 27: 1046-1052.
47. Muiesan ML, Salvetti M, Zulli R, Pasini GF, Bettoni G, Monteduro C, Rizzoni D, Bettoni G, Cinelli A, Porteri E, Corsetti V, Agabiti-Rosei E. Structural association between the carotid artery and the left ventricle in a general population in Northern Italy: the Vobarno study. J Hypertens 1998; 16(Pt 1), 1805-1812. (Pubitemid 28548520)
48. Muiesan ML, Salvetti M, Paini A, Monteduro C, Rosei CA, Aggiusti C, Belotti E, Bertacchini F, Galbassini G, Stassaldi D, Castellano M, Rosei EA. Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study. J Hypertens 2010; 28: 1935-1943.
49. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
50. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158.
51. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T. Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30: 445-448.
52. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57: 1076-1080.